Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Maini is a 3-star analyst with an average return of 12.2% and a 75.00% success rate. Maini covers the Healthcare sector, focusing on stocks such as Sionna Therapeutics, Inc., Tenax Therapeutics, and Tectonic Therapeutic.
In a report released yesterday, Maxim Group also maintained a Buy rating on the stock with a $8.00 price target.
Based on Inhibikase Therapeutics’ latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $16.38 million. In comparison, last year the company had a GAAP net loss of $13.68 million
